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ABSTRACT
Objective: The inflammation and oxidative stress were related together in the generation of reactive oxygen species, which is responsible for the 
enhancement of inflammation associated with various chronic diseases.
Methods: The aim of this study is to synthezise and characterizes the flavones (2-phenyl-1-benzopyran-4-one) derivatives and analyzed by their 
docking hypothetical data as an effective anti-inflammatory mediator against cyclooxygenase-2 (COX-2) enzyme. Further, the evaluation of various 
in  vitro antioxidant and anti-inflammatory studies was carried out.
Results: The 10 compounds were synthesized and characterized by ultraviolet, infrared, nuclear magnetic resonance, and mass spectroscopic 
techniques. The docking data results of these 10 flavones derivatives against COX-2 enzymes (Protein Data Bank ID: 3LN1) showed the binding energy 
ranging between −5.53 kcal/mol and −7.02 kcal/mol when compared with that of the standard diclofenac (−6.34 kcal/mol). The in vitro studies 
suggest that the lipophilic character of the side chain donor, along with the hydroxyl substituted flavones found to have significant half maximal 
inhibitory concentration values.
Conclusion: Based on these in silico and in vitro evaluation results, these synthesized compounds could act as a promising inhibitor to target the COX-
2 enzyme. Hence, those compounds were effective in the management of chronic diseases by exhibits free radical scavenging and anti-inflammatory 
property.
Keywords: Flavone derivatives, Cyclooxygenase-2, Antioxidant, Anti-inflammatory, Molecular docking.
INTRODUCTION
Bioflavonoids or flavonoids are polyphenolic compounds and broadly 
distributed in plants, which acts as a secondary metabolite to the plants. 
Many flavonoids have an excellent antioxidant property and play an 
important role in preventing the major diseases such as cardiac disorder, 
antidiabetic, and anticancer, which are mainly initiated by the development 
of oxidative stress [1,2]. Oxidative stress is an important factor in the origin 
of several diabetic, cancer, cardiovascular, and degenerative diseases [3]. 
The generation of reactive oxygen species (ROS) acts as a core in the 
development of inflammatory diseases due to host defense mechanism 
of polymorphonuclear neutrophils which leads to oxidation of protein 
(tyrosine phosphatase) responsible for the production of an inflammatory 
signal molecule such as peroxiredoxin 2 [4].
The relationship between the oxidative stress and inflammation was 
described in many articles in connection with this, for example, in a 
diabetic condition; the excess of oxidative damage was developed in 
hyperglycemia followed by tissue injury [5]. It was clearly predicted 
that increasing level of nitrite, malondialdehyde, and lipid peroxidation 
leads to decreasing the total antioxidant enzymes of diabetic rat [6]. It 
is also well established that the various anti-inflammatory drugs could 
act by blocking the production of pro-inflammatory prostaglandins 
through the inhibition of cyclooxygenase (COX) [7].
Naturally available polyphenolic phytochemical compounds had a 
capability in scavenging and suppression of ROS and regulate the 
antioxidant defenses as a safeguard [8,9]. Furthermore, it plays a key 
role in ruling the inflammatory cellular activities and also modulates 
the enzyme activities in arachidonic acid and arginine metabolism. 
The molecular mechanisms behind the polyphenols were inhibition 
of enzyme coupled with COX2, inducible nitric oxide synthase (iNOS), 
nuclear factor-kappa B (NF-κB), activating protein-1 (AP-1), and 
stimulating the phase II antioxidant detoxifying enzymes, mitogen-
activated protein kinase, protein kinase C, and some associated 
factors [10,11]. It has been reported that flavonoids have strong 
antioxidant activities; it shows direct scavenging free radicals, 
suppression of pro-inflammatory cytokines through inhibition of ROS 
and nitric oxide, decreasing inflammatory genes including COXs and 
iNOS, upregulating antioxidant enzymes, and modulating transcription 
factors such as NF-κB and AP-1, and enhancing the nuclear factor 
erythroid 2-related factor 2 signaling pathway [12-15].
Based on the above concept, the two pharmacophores, namely 
2-phenyl- 4H- chromen - 4- one (flavones) and hydroxy 
2-phenyl- 4H- chromen - 4- one (hydroxy flavones) with some electron 
withdrawing and donating groups were chosen to produce the target 
compounds. To reveal the theoretical binding pattern of the compounds 
with COX-2, a docking study analysis was carried out using AutoDock 
4.2. software for finding its binding affinity toward the receptor protein 
COX-2 (prostaglandin synthase-2). In addition with this, the targeted 
compounds were subjected for the evaluation of in vitro antioxidant 
and anti-inflammatory properties, which could provide supportive 
evidence between in silico and in vitro pharmacological study.
METHODS
Chemical and reagents
The substituted acetophenones, aromatic aldehydes, hydrogen peroxide, 
aspirin, sodium dihydrogen phosphate, dimethyl sulfoxide (DMSO), 
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dimethylformamide, and methanol were purchased from SRL Pvt., Ltd., 
Mumbai, Merck India, HiMedia Pvt. Ltd, Mumbai, and Loba chemicals, 
Cochin. All the chemicals in this synthesis were of AR and LR grade.
The melting point of the synthesized compounds was determined by an 
open capillary method using digital melting point apparatus. The purity 
and progress of reaction were monitored by thin-layer chromatography 
using the mobile phase as hexane:ethyl acetate (4:1). The spots were 
observed by the ultraviolet (UV) light and iodine fumes. The λ max of 
the synthesized compounds was recorded on Shimadzu ultra-visible 
spectrophotometer. Fourier transform infrared spectrophotometer 
(FTIR) was recorded on Shimadzu FTIR in the range of 4000 cm−1–400 cm1 
using KBr pellet technique. Mass fragmentation for the synthesized 
compounds was recorded using JEOL gas chromatography (GC) mate 
GC-mass spectrometry (GC-MS) spectrometer. Proton nuclear magnetic 
resonance (NMR) spectra were recorded using BRUKER advance III - 500 
MHz FT NMR Spectrometer using the solvent DMSO. Chemical shifts were 
recorded in parts per million and trimethylsilane as an internal standard.
General procedure for the synthesis of flavones derivatives
In the first step, chalcones were synthesized by condensation of an 
equimolar mixture of substituted acetophenone and substituted 
aromatic aldehyde in the presence of strong base under warm condition. 
In the second step, chalcones were cyclized to flavone in the presence 
of oxidizing agent hydrogen peroxide and strong base under the 
temperature between 50 and 70°C [16,17]. The general scheme of the 
synthesis of flavones and the substitution patterns for the synthesized 
compounds F1–F5b and HF1–HF3 were mentioned in Fig. 1 and Table 1.
Molecular modeling study
AutoDock 4.2 was used to identify the binding modes of synthesized 
derivatives responsible for the activity to find the binding energies of 
these synthesized compounds in the active sites. The ligands were 
drawn using ChemDraw Ultra 10.0. The mol form of each ligand was 
converted to Protein Data Bank (PDB) format using Open Babel, before 
the submission for the docking. The preparation of the receptor was 
processed through downloading the crystal structure of enzyme COX-
2 complexed with a selective inhibitor, celecoxib (PDB ID: 3LN1) from 
PDB (http://www. rcsb.org/pdb). The PDB file was imported to Accelrys 
studio viewer where the receptor preparation module was used to 
prepare the protein. All the bound water molecules and heteroatom were 
removed from the complex, both polar and non-polar hydrogen were 
added, and three-dimensional structure of the protein was corrected. 
10 conformations were generated for each ligand. For the discussion of 
active compounds, the top-ranked conformation was considered.
Evaluation of in vitro antioxidant activity
All the synthesized flavones (F1–F5b and HF1–HF3) and the standard 
drug were prepared in the dose of 10, 20, 40, 80, and 160 µg/ml, 
respectively, for performing the in vitro antioxidant activity.
Reducing power ability method
The sample of 2.5 ml of (1 % w/v) potassium ferric cyanide and 
2.5 ml of 0.2 M phosphate buffer (pH 6.6) were added to 1ml of 
various concentrations of the sample and standard (ascorbic acid), 
respectively [18,19]. The reaction mixtures were incubated at 50°C for 
20 min followed by the addition of 2.5 ml (10% w/v) of trichloroacetic 
acid and centrifuged at 3000 rpm for 10 min, soon after 2.5 ml of the 
supernatant was separated, mixed with 0.5 ml (0.1 % w/v) of ferric 
chloride and 2.5 ml of distilled water. The absorbance of the resulting 
solutions was measured at 700 nm against the blank.
Hydroxyl radical scavenging method
About 1 ml of iron-ethylenediaminetetraacetic acid (EDTA) solution, 
0.5 ml of 0.018 % EDTA, 1 ml of DMSO (0.85% in 0.1 M/l phosphate 
buffer pH 7.4), and 0.5 ml of ascorbic acid were added to each sample and 
standard (gallic acid), respectively. The reaction mixtures were heated 
for 15 min at 80–90°C and 1 ml of cold trichloroacetic acid (17.5%) was 
added to terminate the reaction. After that, 3 ml of Nash reagent (75 g 
of ammonium acetate, 2 ml of acetylacetone, and 3 ml of glacial acetic 
acid) was added and incubated for 15 min at room temperature, and 
absorbance was measured at 412 nm using the blank [20].
Nitric oxide scavenging assay method
About 1 ml of different concentration of synthesized flavones was added 
with 0.5 ml of 5 mM of sodium nitroprusside in phosphate buffered 
saline pH 7.4 and incubated for 180 min at 25°C. The reaction mixture 
was mixed with equal volume of Griess reagent (1% sulfanilamide and 
0.1% naphthyl ethylenediamine dihydrochloride in 5% phosphoric 
acid), which results in color formation by diazotization of nitrite ions 
with naphthyl ethylenediamine dihydrochloride and sulfanilamide. The 
absorbance of chromophore was measured at 540 nm using blank [21]. 
The percentage inhibition of radical formation by the above methods 
was calculated by the following formula.
% Inhibition=Ac–At/Ac×100; Where, At=Absorbance of test, 
Ac=Absorbance of control.
Evaluation of in vitro anti-inflammatory activity
All synthesized flavones (F1–F5b and HF1–HF3) and the standard drug 
were prepared in the dose of 10, 20, 40, 80, and 160 µg/ml, respectively, 
for performing the anti-inflammatory activity.
Denaturation of the protein albumin
Respective concentrations of 2 ml sample and standard (diclofenac) 
were added with 2.8 ml of phosphate buffered saline (pH 6.4) and 
mixed with egg albumin (0.2 ml) taken from fresh hen’s egg followed by 
incubation for 15 min at 27°C. After incubation, the denaturation was 
produced by boiling the reaction mixture at 70°C for 10 min, later was 
cooled and measured the absorbance of turbidity at 660 nm against 
blank [22].
Membrane stabilizing activity
The sheep blood was collected and mixed with the equal volume of 
sterilized Alsever’s solution. The resulting solution was centrifuged at 
3000 rpm and separated the packed cells. Packed cells were washed 
with isosaline (0. 85% in pH 7.4) and made 10% v/v suspension with 
isosaline. The 0.5 ml red blood cell suspension was added with 2 ml 
different concentration of synthesized flavones and the standard 
diclofenac. The 1 ml of 0.15 M, pH 7.4 phosphate buffer, and 2 ml of 
0.36% of hyposaline were added and incubated for 30 min at room 
temperature followed by centrifugation at 3000 rpm. The supernatant 
Fig. 1: General Synthetic scheme of flavones
Table 1: Substitution pattern of flavones derivatives
Compound R1 R2 Compound R1 R2
F1 -H -C6H5 F5a -H -C6H4-CH=CH
F2 -H -C6H4-2(Cl) F5b -H -C4H3O
F3 -H -C6H4-4(Cl) HF1 -OH -C6H4-2(Cl)
F4 -H -C6H4-4(F) HF2 -OH -C6H4-4(Cl)
F5 -H -C6H4-2(NO2) HF3 -OH -C6H3-2,4(Cl)
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liquid was separated and the hemoglobin content of that solution 
estimated at 560 nm against blank [23,24]. The percentage inhibition 
of radical formation and anti-inflammatory property was calculated by 
the following formula.
% Inhibition=Ac–At/Ac×100; Where, At=Absorbance of test, 
Ac=Absorbance of control.
Statistical analysis
Experimental results were expressed as mean±standard error mean 
of three parallel measurements. Differences between control and test 
groups were tested for significance using one-way analysis of variance 
followed by Dunnett’s t-test.
RESULTS AND DISCUSSION
Synthesis and characterization of flavones
The various derivatives of flavones were synthesized according to the 
protocol reported in the general scheme of synthesis. The percentage 
yields of the synthesized flavones were obtained moderately, and a 
melting point of those compounds was also recorded and presented 
uncorrected. The purity of the each synthesized compounds was 
determined by thin-layer chromatography. All the synthesized 
compounds were characterized by various spectroscopic techniques 
such as UV, IR, 1H-NMR, and MS.
2-phenyl-4H-chromen-4-one (F1). MP: 130–132°C; Rf=0.56; % 
yield=65.3% w/w; UV λmax: CHCl3, nm: 297; IR (KBr/cm): 1739 
(lactone), 1643 (CO str.), 1585, 1550 (C=C Arom.str.), 1134, 1093 (COC 
str.), 771 (C-C bending); 1H NMR (500 MHZ, DMSO): δ 7.4–7.9 (m, 8H, 
ArH), 6.9 (m, 1H, ArH); m/z: 222(M+), 120.7 (C7H6O2)+, 105.8 (C7H8)+, 
92.8 (C6H6O)+, 77.9 (C6H5)+.
3-(2-chlorophenyl)-4H-1-benzopyran-4-one (F2). MP: 157–160°C; 
Rf=0.3; % yield=42.4% w/w; UV λmax: CHCl3, nm: 241; IR (KBr/cm): 
1797 (lactone), 1687 (CO str.), 1593, 1564 (C=C Arom.str.), 1124, 1103, 
1037 (COC str.), 754 (C-C bending); 1H NMR (500 MHZ, DMSO): δ 6.6 (m, 
1H, ArH), 7.4–7.8 (m, 8H, ArH); m/z: 256 (M+), 138.9 (C8H7 Cl)+, 120.9 
(C7H6O2)+, 91.9 (C6H5O), 77 (C6H5)+.
3-(4-chlorophenyl)-4H-1-benzopyran-4-one (F3). MP: 167–170°C; 
Rf=0.84; % yield=40.4% w/w; UV λmax: CHCl3, nm: 261; IR (KBr/cm) 
1735 (lactone), 1685 (CO str.), 1593, 1573 (C=C Arom.str.), 1130, 1091 
(COC str.), 761 (C-C bending); 1H NMR (500 MHZ, DMSO): δ 7.4–7.9 
(m, 8H, ArH), 6.7 (m, 1H, ArH); m/z: 256(M+), 121.6(C7H6O2)+, 139.5 
(C8H7Cl)+, 76.6 (C6H5)+.
2-(4-fluorophenyl)-4H-chromen-4-one (F4). MP: 241–243°C; Rf=0.85; 
% yield=59.3% w/w; UV λmax: CHCl3, nm: 250; IR (KBr/cm): 1772 
(lactone), 1685 (CO str.), 1577, 1514 (C=C Arom.str.), 1126, 1107, 1024 
(COC str.), 773 (C-C bending); 1H NMR (500 MHZ, DMSO): δ 6.9 (m, 1H, 
ArH), 7.6–8.6 (m, 8H, ArH); m/z: 240(M+), 122 (C7H6O2)+, 119.5 (C8H6 
F)+, 75.5 (C6H3)+.
3-(2-nitrophenyl)-4H-1-benzopyran-4-one (F5). MP: 145–148°C; 
Rf=0.43; % yield=51.6% w/w; UV λmax: DMSO, nm: 306; IR (KBr/cm): 
1797 (lactone), 1681 (CO str.), 1593, 1573 (C=C Arom.str.), 1128, 1091 
(COC str.), 761 (C-C bending); 1H NMR (500 MHZ, DMSO): δ 7.4–7.6 
(m, 8H, ArH), 6.2 (m, 1H, ArH); m/z: 267 (M+), 121.1 (C7H6O2)+, 148.9 
(C8H7NO2)+, 76.9 (C6H5)+.
2-[(Z)-2-phenylethenyl]-4H-chromen-4-one (F5a). MP: 152–155°C; 
Rf=0.76; % yield=55.3 % w/w; UV λmax: CHCl3, nm: 299; IR (KBr/
cm): 1788 (lactone), 1699 (CO str.), 1583, 1554 (C=C Arom.str.), 1107, 
1213 (COC str.), 769 (C-C bending), 3093 (C-H str.); 1H NMR(500 MHZ, 
DMSO): δ 3.3 (s, 1H), 6.8 (m, 1H, ArH), 7.3–7.8 (m, 9H, ArH); m/z: 248 
(M+), 131 (C10H10O)+, 121 (C7H6O2)+, 106 (C8H9)+, 78(C6H5)+.
2-(furan-2-yl)-4H-chromen-4-one (F5b). MP: 164–168°C; Rf=0.48; 
% yield=50.4% w/w; UV λmax: CH3OH, nm: 246; IR (KBr/cm): 1731 
(lactone), 1677 (CO str.), 1514, 1541 (C=C Arom.str.), 1024, 1137 (COC 
str.), 763 (C-C bending), 3058 (C-H str.); 1H NMR(500 MHZ, DMSO): 
δ 6.8–6.9 (m, 1H, ArH), 7.1–7.5 (m, 7H, ArH); m/z: 213 (M+), 92.5 
(C6H5O)+, 122.4 (C7H6O2)+, 76.6 (C6H5)+.
2-(2-chlorophenyl)-7-hydroxy-4H-chromen-4-one (HF1). MP: 172–
175°C; Rf=0.68; % yield=64.4% w/w; UV λmax: CH3OH, nm: 358; IR 
(KBr/cm): 1701 (lactone), 1683 (CO str.), 1541, 1558 (C=C Arom.str.), 
1020, 1218 (COC str.), 771 (C-C bending), 3033 (C-H str.), 3461 (OH 
str.); 1H NMR(500 MHZ, DMSO): δ 6.6 (m, 1H, ArH), 7.4–7.9 (m, 7H, 
ArH), 9.4 (s, 1H, OH); m/z: 272 (M+), 237.05 (C15H10O3)+, 138 (C7H6O3) +, 
103 (C8H7)+, 77.9(C6H5)+.
2-(4-chlorophenyl)-7-hydroxy-4H-chromen-4-one (HF2). MP: 182–
184°C; Rf=0.52; % yield=69.3% w/w; UV λmax: CH3OH, nm: 232; IR 
(KBr/cm): 1789 (lactone), 1683 (CO str.), 1510, 1542 (C=C Arom.str.), 
1095, 1130 (COC str.), 769 (C-C bending), 3080 (C-H str.), 3442 (OH str); 
1H NMR(500 MHZ, DMSO): δ 6.5 (m, 1H, ArH), 7.5–7.9 (m, 7H, ArH), 9.5 
(s, 1H, OH); m/z: 272 (m+1), 137 (C7H5O3)+, 104 (C8H8)+, 76.8 (C6H5)+.
2-(2,4-dichlorophenyl)-7-hydroxy-4H-chromen-4-one (HF3). MP: 
175–178°C; Rf=0.81; % yield=55.6% w/w; UV λmax: CH3OH, nm: 303; 
IR (KBr/cm): 1714 (lactone), 1649 (CO str.), 1510, 1541 (C=C Arom.
str.), 1217, 1247 (COC str.), 771 (C-C bending), 3033 (C-H str.), 3479 
(OH str.); 1H NMR(500 MHZ, DMSO): δ 6.6 (m, 1H, ArH), 7.3–7.9 (m, 6H, 
ArH), 9.4 (s, 1H, OH); m/z: 307 (M+), 138.7 (C7H6O3)+, 172.4 (C8H6Cl2)+, 
123.6 (C7H6O2), 76.7 (C6H5)+.
Molecular docking study
The binding interactions of flavones toward the protein COX-2 (PDB ID: 
3LN1) using docking studies by AutoDock 4.2. software [25,26] were 
revealed on the basis of structure-based design. The most favorable 
docking poses of the 10 docked conformations for each molecule were 
analyzed for further investigation of the ligand interactions within 
the active sites of the receptor. The wonderful number of interactions 
with the active site residues coupled with minimum favorable binding 
energy state. Hence, it was considered that these compounds may serve 
as an effective replacement agent for the anti-inflammatory drugs and 
thereby associated chronic disease.
All the synthesized compounds have a higher binding affinity with 
the receptors, in the narrow range of binding energy for the protein 
PDB ID: 3LN1 and showed the docking score value in the range of 
−5.53–−7.02 kcal/mol and this result suggests that few synthesized 
compounds showed a good docking score value, which is compared to 
that of reference drug diclofenac (−6.34 kcal/mol) (Table 2).
Among these 10 synthesized compounds, the best three compounds, 
namely F5, HF1, and HF3 were showed the best docking score 
and the interaction within the receptor, which was compared with 
standard diclofenac and visualized by the discovery studio (Fig. 2). 
Those compounds were studied for their electrostatic, hydrophobic 
bonding, and hydrogen bonding interactions on the receptor site, in 
which the compound HF1 showed their binding score (−6.83 kcal/
mol) and possess the alkyl/pi-alkyl interactions on lipophilic side chain 
substitution with Ile 484 and Phe 464 would help for the activity. In 
compound HF1, interactions over pi-cation on Lys 478 and for pi-donar 
hydrogen bond interaction with Phe 464 and Glu 465 on benzopyrone 
moiety were favourable for the pharmacological activity. Whereas the 
compound HF3 observed the highest binding score (−7.02 kcal/mol) 
and present within the binding pocket region forming conventional 
hydrogen bond and pi-cation interaction of benzopyrone ring with 
Lys 478 could favor the action. The alkyl/pi-alkyl interaction with the 
lipophilic side chain substitution along with the presence of hydroxyl 
group at position 7 shows stabilized interaction with basic amino acid 
residues Ile 484, Phe 464, Ala 474, and Lys 478.
In vitro antioxidant activity
The 10 synthesized flavones (F1–F5b and HF1–HF3) and its 
corresponding reference drug were evaluated for in vitro antioxidant 
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studies and the results were shown for reducing power ability method 
(Table 3), hydroxyl radical scavenging method (Table 4), and nitric 
oxide radical scavenging assay (Table 5), respectively.
In reducing power assay method, the antioxidant compound has the 
ability to donate electron which neutralizes the free radicals. This is 
shown by conversion of the oxidized form of iron complex (Fe3+) to the 
reduced form of ferrous complex (Fe2+) which was indicated by Prussian 
blue color. Due to reducing power ability of synthesized flavones, the 
absorbance increases with increasing concentration. Among the all 10 
synthesized flavones, the flavone with lipophilic in nature along with the 
presence of hydroxyl group, namely F2, F3, F4, HF1, HF2, and HF3 possess 
the noteworthy results when compared to that of the standard, (Table 3).
Hydroxyl radical is one of the free radical existed in our body, which 
is highly ROS responsible for attacking some of the substrates in 
our biological system such as carbohydrates, proteins, DNA, and 
polyunsaturated fatty acids. The ascorbic acid - Iron EDTA was 
responsible for the generation of hydroxyl radical in the presence of 
DMSO to form formaldehyde, which further converted into hydroxyl 
radicals. These radicals formation was identified by a nash reagent by 
the yellow colored complex formation. The optical density of this yellow 
color formation was decreased while increasing in the concentration of 
compounds. Due to the ability to donate proton toward the hydroxyl 
radical was retarded the formation of yellow color. By compared with 
the standard drug, the synthesized flavones with lipophilic side chain 
substitution along with hydroxyl substitution at their basic analog, 
namely F2, F3, F4, HF1, HF2, and HF3 have significantly inhibited the 
color formation by acting as an antioxidant (Table 4).
In general, nitric oxide radicals were generated in our body from the 
amino acid (L - arginine) which are present on our endothelial cells and 
phagocytes. These free radicals contain an unpaired electron which 
reacts with superoxide anion to form peroxynitrite (ONO.) [27,28]. 
These radicals were highly toxic and produced inflammation due to 
cellular damage results in juvenile diabetes, various sclerosis, ulcerative, 
arthritis, and so on [29]. Due to this reason, the present study deals with in 
vitro scavenging of nitric oxide assay of synthesised flavones in different 
concentrations. In this method, the sodium nitroprusside acts as a source 
for the generation of nitric oxide. This nitric oxide further reacts with 
the oxygen to form nitrite ions. Griess reagent contains sulfanilamide, 
which undergoes diazotization with nitrite ions and a forms diazonium 
salt, which couples with the naphthyl ethylene diamine to form a pink 
color complex. The scavenging of nitric oxide was directly related with 
decreasing of the optical density of pink color complex. Due to antioxidant 
property of synthesized compounds, which compete with oxygen 
interaction on nitric oxide to form the nitrite radicals, by which it retards 
the reaction along with Griess reagent to form the pink color. This clearly 
indicates that the concentration of the drug is inversely proportional to 
the absorbance [30]. As like the above methods, the percentage inhibition 
of the synthesized flavones with hydroxyl substitution (HF1 to HF3) was 
posses the significant result in scavenging of nitric oxide radicals by 
compared with the reference drug. The IC50 values of HF1, HF2, and HF3 
showed significantly 38.0, 29.6, and 28.8 µg/ml, respectively (Table 5).
In vitro anti-inflammatory activity
The generation of ROS may act as a hub in the development of 
inflammatory diseases due to the host defense mechanism which 
leads to oxidation of protein, which is responsible for the production 
of pro-inflammatory signals. On this concept, denaturation of protein is 
one of the well-documented causes of inflammation [31,32]. The anti-
Fig. 2: Three-dimensional and two-dimensional structure of ligand-receptor interaction of the compounds HF1 and HF3, respectively, with 
PDB ID: 3LN1
Table 2: Best docking score of synthesized derivatives of 









F1 −6.45 F5a −6.26
F2 −5.53 F5b −5.52
F3 −5.96 HF1 −6.83
F4 −6.17 HF2 −6.33
F5 −6.69 HF3 −7.02
COX-2: Cyclooxygenase-2, PDB: Protein Data Bank
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inflammatory drugs, for example, salicylic acid and phenylbutazone 
had shown dose-dependent ability to prevent thermally induced 
protein denaturation. The denaturation is used loosely to designate 
the change of proteins from a soluble to an insoluble form brought 
about by a large variety of chemical and physical agents including 
acids, alkalies, alcohol, acetone, salts of heavy metals, dyes, heat, light, 
and pressure. On the other hand, the hemolytic effect of hypotonic 
solution related to the excessive accumulation of fluid within the cell 
resulting in the rupturing of RBC membrane. Due to this reason, the 
RBC was more susceptible to secondary damage through free radical-
induced lipid peroxidation. Hence, the membrane stabilization helpful 
in the prevention of leakage of serum protein and fluids into the tissues 
during increased permeability caused by the inflammatory mediators. 
The results showed that the synthetic flavones which perhaps the 
stabilized RBC membrane by preventing the release of lytic enzymes 
and active mediators of inflammation.
Inflammation is a biological response toward the tissue injury or 
damage along with infection, which is probably due to heat, pain, 
redness, swelling, and some abnormal physiological activities. The 
cellular damage or injury occurs due to microbial agents or chemical 
substances or by physical trauma. In these conditions, the chemical 
mediators are released from the injured tissues to disturb the tissue 
repair [33]. Due to this reason, nonsteroidal anti-inflammatory drugs 
(NSAID’s) are administered for the management of inflammation, but 
those are produced gastric irritation leads to the formation of gastric 
Table 3: Antioxidant effect of synthesized flavones by reducing power ability method
Compounds Absorbance
10 µg/ml 20 µg/ml 40 µg/ml 80 µg/ml 160 µg/ml
F1 0.034±0.001 0.046±0.002 0.075±0.001 0.126±0.007 0.188±0.010
F2 0.143±0.017 0.354±0.016 0.518±0.032 0.671±0.042 0.793±0.053
F3 0.128±0.019 0.342±0.011 0.552±0.028 0.695±0.050 0.806±0.064
F4 0.239±0.010 0.388±0.021 0.505±0.002 0.631±0.060 0.789±0.068
F5 0.086±0.002 0.126±0.009 0.182±0.002 0.258±0.012 0.311±0.020
F5a 0.038±0.002 0.096±0.002 0.159±0.007 0.208±0.019 0.275±0.020
F5b 0.072±0.004 0.155±0.008 0.201±0.015 0.289±0.024 0.342±0.017
HF1 0.278±0.014 0.412±0.028 0.596±0.034 0.729±0.058 0.874±0.07
HF2 0.263±0.020 0.390±0.014 0.503±0.029 0.624±0.042 0.710±0.056
HF3 0.321±0.016 0.439±0.026 0.561±0.031 0.648±0.046 0.733±0.049
Ascorbic Acid 0.361±0.018 0.522±0.031 0.669±0.046 0.792±0.047 0.923±0.055
All values are mean±SEM, n=3. One-way analysis of variance followed by Dunnett’s test was performed as the test of significance. SEM: Standard error mean
Table 4: Antioxidant effect of synthesized flavones by hydroxyl radical scavenging assay
Compounds % Hydroxyl radical scavenging assay
10 µg/ml 20 µg/ml 40 µg/ml 80 µg/ml 160 µg/ml IC50
F1 9.87±0.69 18.45±1.85 30.55±3.18 48.16±1.41 65.62±1.8 105.4
F2 14.86±0.94 25.67±1.56 39.63±2.74 65.77±3.22 74.05±3.62 77.6
F3 9.01±0.72 16.29±1.69 29.51±1.72 60.48±1.65 72.31±3.39 91.3
F4 10.49±0.62 17.43±0.87 38.86±1.61 50.29±1.27 66.01±3.02 100
F5 6.89±0.44 10.94±0.63 16.4±1.55 25.34±1.52 32.12±2.91 -
F5a 6.93±0.36 9.52±0.67 16.58±1.18 24.29±2.16 36.3±1.44 -
F5b 7.82±0.88 10.45±0.74 17.02±1.25 23.45±1.98 30.85±0.98 -
HF1 18.02±1.86 35.53±3.03 49.79±3.19 71.01±4.18 90.19±4.27 55.4
HF2 13.22±1.09 22.12±2.65 48.67±2.98 69.18±3.96 88.74±4.18 65.4
HF3 19.45±2.14 30.75±2.92 50.1±3.46 72.85±4.41 91.04±4.72 55.9
Gallic acid 21.96±1.63 38.27±3.18 55.69±3.54 73.21±3.72 95.57±4.67 46.7
All values are mean±SEM, n=3. One-way Analysis of Variance followed by Dunnett’s test was performed as the test of significance. IC50: Half maximal inhibitory 
concentration. SEM: Standard error mean
Table 5: Antioxidant effect of synthesized flavones by nitric oxide scavenging assay
Compounds % Inhibition of nitric oxide scavenging
10 µg/ml 20 µg/ml 40 µg/ml 80 µg/ml 160 µg/ml IC50
F1 17.45±0.57 23.57±0.49 35.75±2.14 42.24±2.96 49.84±2.57 -
F2 13.79±0.49 24.65±1.29 36.83±0.95 48.81±2.41 57.98±2.92 112.8
F3 4.27±0.21 9.96±0.58 18.98±0.44 25.94±1.36 34.96±1.29 -
F4 14.63±0.54 25.17±1.45 37.03±1.52 49.84±2.41 64.01±2.63 101.2
F5 3.32±0.19 8.54±0.33 18.51±0.63 24.36±1.35 33.86±1.56 -
F5a 4.52±0.27 7.59±0.36 15.18±1.29 22.15±1.32 29.11±1.74 -
F5b 4.27±0.29 9.96±0.69 16.93±1.53 22.62±1.38 31.01±2.17 -
HF1 30.53±1.83 43.98±2.63 57.43±2.39 72.46±1.34 87.02±2.22 38.0
HF2 28.48±1.70 43.03±2.16 59.33±1.86 74.05±2.44 87.65±2.25 38.2
HF3 26.4±1.55 44.24±1.92 59.8±2.45 74.36±2.29 86.52±2.73 38.7
Gallic Acid 32.27±1.93 45.25±2.46 62.34±1.74 80.22±2.56 98.1±2.88 28.8
All values are mean±SEM, n=3. One-way Analysis of Variance followed by Dunnett’s test was performed as the test of significance. IC50: Half maximal inhibitory 
concentration. SEM: Standard error mean
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ulcer [34]. Natural products are our traditional medicines which are 
used to overcome the adverse effects in the development of the modern 
medical field.
Hence, in the present study, the naturally mimicking synthesized 
compounds were evaluated for in vitro anti-inflammatory activity by 
denaturation of protein and membrane stabilizing activity. Protein 
denaturation is one of the common causes during rheumatoid 
arthritis [35,36]. Therefore, the synthesized flavones which prevent 
the denaturation of protein would be a potent anti-inflammatory drug. 
Thus, the drug effective against the protein denaturation is a common 
mechanism [31] before evaluating the inhibitory effect of COX [32].
One of the common methods for evaluation of in vitro anti-
inflammatory activity was a membrane stabilizing method. In this 
method, hypotonicity was induced for lysis of erythrocytes which 
explored by our synthesized flavones due to the well-stabilizing effect 
of erythrocytes. Lysosome membrane stabilization was important for 
inflammatory response, by overcoming the leakage of constituents 
inside the lysosomes such as neutrophils, protease, and bactericidal 
enzymes. Those were highly toxic in the development of inflammation 
and lead to tissue damage [37]. By which, stabilization of membrane 
was an important factor for NSAIDs as an anti-inflammatory effect. 
Hence, the synthesized flavones (F2, F3, F4, HF1, HF2, and HF3) 
were possess the significant result by the protection of membrane 
stabilization through hypotonicity induced lysis (Table 6).
Based on this fact, the percentage inhibition of protein denaturation and 
hemolysis (Table 6 and Fig. 3) by synthesized flavones was increases 
by increasing concentration when compared with the standard. The 
synthesized flavones with hydroxyl substitution (HF1–HF3) showed 
the significant IC50 values.
CONCLUSION
The study deals with the synthesis and characterization of flavones by 
various spectroscopic techniques. An in silico docking studies of the 
10 target molecules with COX-2 enzyme results showed that the best 
docking score was obtained for the target molecules are in the range of 
−5.35–7.02 kcal/mol. This effect is payable to the presence of hydroxyl 
group in 2-phenyl-1-benzopyran-4-one moiety with its structure. On 
docking study results, it was quite understood that all the basic analog 
of this synthesized compounds showed a best target protein interaction, 
which was further confirmed by its least binding score. These 
synthetic compounds were subjected for in vitro antioxidant and anti-
inflammatory activity. Based on the results, the synthesized flavones 
with lipophilic side chain donor atom at the side chain substitution also 
with a hydroxyl group at position 7 of flavones moiety, namely F2, F3, 
F4, HF1, HF2, and HF3 were showed the significant scavenging effect on 
free radicals and inhibition of inflammation process when compared 
with a standard drug. Thus, this study concluded that the synthesized 
flavones especially with hydroxyl substitution along with 2-chloro, 
4-chloro, and 2,4-dichloro groups were possess a great efficacy in anti-
inflammatory activity and act as an anti-proinflammatory mediator. In 
evidence with the available literature, the anti-inflammatory property 
depends on the lipophilicity character of the flavones derivatives, which 
promotes the binding interaction with COX-2.
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